The direct answer: choose the AMI product by the problem you want assessed, not by which box sounds strongest. AMI Eyes is the 1% PN option positioned for delicate under-eye skin quality. AMI Plus X is the 2% PN option for broader facial, neck, décolletage or hand rejuvenation. AMI Tone Up combines PN with plant-derived extracellular-vesicle ingredients and a brightening complex for uneven tone and dullness. AMI NAD+ uses an NAD+/NMN/PDRN concept, but has the largest gap between biochemical marketing and product-specific human evidence. AMI Peptox is a peptide skin booster for fine lines and texture; despite its name, it is not botulinum toxin and should not be expected to relax muscles like a toxin treatment. The AMI range comes from Quiver Medic, while MJS supplies it as a distributor.
There is no evidence-based “best AMI booster” for everyone. A good decision begins with the cause of the concern, the complete current label, and the strength of evidence for the finished product—not the number of vials in the box.
How this guide grades evidence: product identity and presentation are checked against current product documentation. Commercial treatment programmes and aftercare timings are kept separate from independent studies, which may explain an ingredient class but are not treated as trials of the finished AMI formula. Social posts are used only to identify customer questions, never to prove results or teach injection technique.
Which AMI skin booster should you choose?
The simplest choice is AMI Eyes for delicate eye-area skin, Plus X for higher-concentration PN over larger areas, Tone Up when pigment and dullness lead the decision, NAD+ when a buyer specifically wants that experimental ingredient concept, and Peptox when peptides and superficial line quality are the priority.
| Product | Best matched concern | Headline formula confirmed in current product material | Evidence-aware decision |
|---|---|---|---|
| AMI Eyes | Crepey under-eye texture, fine lines and skin-quality-related shadowing | 1% PN; 2 mL pre-filled syringe | The most logical AMI starting point for thin periocular skin, but it cannot correct every type of dark circle or replace true volume restoration |
| AMI Plus X | General facial, neck, décolletage or hand skin quality; texture, elasticity and fine lines | 2% PN; 2 mL pre-filled syringe | Double the PN concentration of Eyes, but not proven to deliver twice the result or twice the duration |
| AMI Tone Up | Uneven tone, dullness and a brightening-led plan | PN + plant-derived “vegan exosome” ingredient; current product materials also list glutathione, niacinamide and tranexamic acid | The formula has a plausible multi-pathway brightening rationale, but ingredient studies do not establish the performance of the finished AMI product |
| AMI NAD+ | Buyers exploring an NAD+/NMN-focused skin-quality programme | NAD+ + NMN + PDRN; 5 mL vial | Biologically interesting, but no controlled AMI NAD+ facial-rejuvenation trial was located; exact active concentrations should be checked on the current label |
| AMI Peptox | Fine lines, texture, firmness and tone where a peptide formula is preferred | Acetyl Hexapeptide-8 at 5,000 ppm; 5 mL vial | A peptide booster, not a toxin. Evidence for acetyl hexapeptide-8 in topical blends or patches cannot be converted into a Botox-equivalent claim |
Choose by diagnosis, not by a single symptom word
“Dark circles,” “dullness” and “wrinkles” each have more than one cause. Under-eye darkness may come from thin skin and visible vessels, pigment, shadow from a hollow, fluid retention, dermatitis or a combination. Facial pigmentation may be melasma, post-inflammatory hyperpigmentation, sun damage or another condition. A peptide booster may address the look of fine lines, but it cannot reproduce the neuromuscular action of botulinum toxin.
This is why AMI Eyes is not automatically the answer to every under-eye complaint, Tone Up is not a diagnosis or cure for melasma, and Peptox should not be selected simply because its name resembles Botox.
AMI Eyes vs AMI Plus X: what does 1% versus 2% PN really mean?
AMI Plus X contains twice the stated PN concentration of AMI Eyes, but concentration alone does not prove a two-fold clinical benefit. AMI Eyes is listed as 1% PN in 2 mL, equivalent to 10 mg/mL and 20 mg in the full syringe. AMI Plus X is listed as 2% PN in 2 mL, equivalent to 20 mg/mL and 40 mg in the full syringe.
| Question | AMI Eyes | AMI Plus X | What matters clinically |
|---|---|---|---|
| PN concentration | 1% = 10 mg/mL | 2% = 20 mg/mL | This is a concentration comparison, not an outcome comparison |
| Total PN in 2 mL | 20 mg | 40 mg | Total content still does not determine the amount appropriate for a person or area |
| Main positioning | Delicate periocular skin | Face, neck, décolletage and hands | Tissue thickness, concern and current instructions for use matter more than “higher is better” |
| Expected type of change | Gradual skin-quality improvement rather than filler-like projection | Gradual improvement in texture, hydration and elasticity rather than structural filling | Neither product should be sold as a substitute for assessment of a true hollow or volume deficit |
| Comparative evidence | No controlled AMI Eyes-versus-Plus X outcome trial was located | No controlled AMI Eyes-versus-Plus X outcome trial was located | Do not promise that Plus X works faster, better or longer solely because it is 2% |
The current AMI Eyes product page confirms 1% PN, 20 mg in one 2 mL syringe and purified salmon-milt DNA. The distinction is useful: Eyes offers a lower-concentration presentation for a delicate area; Plus X provides a higher PN concentration for broader skin-quality goals. It is not a ranking of which product is universally superior.
Can AMI Eyes fill tear trough hollows?
AMI Eyes may improve the appearance of skin quality around a shallow shadow, but it is not a cross-linked dermal filler and should not be presented as a predictable replacement for lost volume. Someone whose “dark circle” is mainly a deep skeletal hollow, prominent fat pad, edema or pigment may need a different plan—or may not be a suitable candidate for an injectable treatment at all.
This distinction is especially important because social discussions often judge the product against a goal it was not designed to achieve. Better hydration or dermal quality can make an eye area look fresher without rebuilding the three-dimensional support that a true hollow lacks.
Why might the AMI ingredients work?
The strongest independent rationale in this range belongs to the PN/PDRN ingredient class, but even that evidence is still limited and is mostly based on products other than AMI. Tone Up’s brighteners and Peptox’s peptides have ingredient-level support in other formulations. NAD+/NMN has a sound role in cell biology, yet the step from that biology to visible results from AMI NAD+ remains unproven.
PN and PDRN: a regenerative signal, not instant filler volume
Polynucleotides are purified DNA-chain materials used in regenerative and aesthetic medicine. PDRN refers to shorter DNA fragments within the same broad family; the terms are sometimes blurred in marketing, but they are not automatically identical formulations. In the AMI range, Eyes and Plus X are labelled PN, Tone Up includes PN, and NAD+ is listed with PDRN.
Laboratory and clinical literature proposes several overlapping actions: binding water, supporting extracellular-matrix repair, moderating inflammation and encouraging fibroblast activity. A 2025 systematic review found nine low- or moderate-quality studies involving 219 people. Several reported improvements in wrinkles, texture and elasticity, with generally mild, temporary adverse effects. The same review found limited agreement on optimal use and called for better trials.
That evidence makes PN a plausible skin-quality treatment class. It does not prove that AMI Eyes removes dark circles, that Plus X delivers a specific percentage of collagen increase, or that either product lasts for a guaranteed number of months.
Tone Up: why combine PN, brighteners and plant-derived extracellular vesicles?
Tone Up is designed around three different jobs: PN for skin-quality support, pigment-pathway ingredients for tone, and a plant-derived extracellular-vesicle component as an emerging delivery or signalling concept. Current product material describes it as combining a plant-derived “vegan exosome” component with a salmon ingredient. Therefore, “vegan” describes the exosome component—not the whole product.
Published AMI Tone Up material names glutathione, niacinamide and tranexamic acid in the brightening complex. Niacinamide can reduce melanosome transfer and support the skin barrier, while tranexamic acid is used in pigmentation management through pathways linked to inflammation and melanogenesis. In an eight-week randomized trial, a topical cream containing 2% niacinamide plus 2% tranexamic acid outperformed its vehicle for irregular facial pigmentation. That topical formulation study supports the ingredient rationale, not the efficacy, route or treatment schedule of AMI Tone Up.
Plant-derived extracellular vesicles are a much earlier evidence category. A 2026 dermatology review found promising regenerative and barrier-related mechanisms, but emphasized that clinical data remain limited and production and characterization methods vary. Customers should ask what the current Tone Up label actually specifies rather than treating the word “exosome” as proof of a standardized clinical effect.
NAD+ and NMN: important molecules, but not proof of “age reversal”
NAD+ is central to energy metabolism and DNA-repair signalling, while NMN is one precursor the body can use to make NAD+; that relationship explains the formula concept but does not establish a visible AMI result. PDRN, niacinamide, adenosine and panthenol are also listed in published AMI NAD+ material, although the available product material does not publish their quantitative concentrations.
A critical Endocrine Reviews assessment concluded that NAD biology is compelling and early human work justifies further trials, while the pharmacology and therapeutic benefits of NAD+ augmentation remain incompletely understood. Much of that human research involves oral precursors and systemic outcomes, not a facial AMI formulation. No controlled, peer-reviewed trial of the finished AMI NAD+ product for facial rejuvenation was located during this review.
The honest buying message is therefore narrower than an age-reversal promise: AMI NAD+ offers an NAD+/NMN/PDRN formulation concept. Its comparative advantage, visible effect size and ideal maintenance interval are not yet established by independent product-specific trials.
Peptox: what does Acetyl Hexapeptide-8 do, and is it Botox?
Acetyl Hexapeptide-8 is a cosmetic peptide, not botulinum toxin. AMI Peptox lists it at 5,000 ppm, which equals 0.5% of the formula. Current MJS product information also lists palmitoyl tetrapeptide-7, a dipeptide, arbutin and adenosine; buyers should verify the complete current INCI or instructions because short public summaries may name only the headline peptide.
Acetyl Hexapeptide-8 is often marketed for expression lines because it is designed to influence part of the signalling sequence involved in muscle contraction. However, a topical peptide and an injected neurotoxin are not interchangeable in molecular action, dose, evidence or expected result. A randomized split-face study of a dissolving microneedle patch containing Acetyl Hexapeptide-8 reported improvement in wrinkles and hydration compared with a patch alone, but that was a different delivery system and not AMI Peptox. It supports further study of the peptide; it does not justify promising toxin-like muscle relaxation.
What results are realistic, and when should you judge them?
Judge regenerative skin boosters over weeks, not the morning after treatment. Immediate swelling, temporary plumping or surface glow may appear early, but they are not the same as a sustained change in texture, tone or dermal quality.
| Time | What may be happening | How to interpret it |
|---|---|---|
| First 24–72 hours | Redness, small raised points, tenderness, bruising or swelling; the under-eye area may look temporarily fuller | Do not use this phase as the “after” result. Worsening or unusual symptoms need assessment |
| Weeks 2–4 | Early hydration, texture or brightness changes may become easier to compare as swelling settles | Use standardized photos and the same lighting; one subtle change does not prove the full course has peaked |
| Weeks 8–12 | A more useful checkpoint for a multi-session regenerative course | Decide whether the original concern actually improved before automatically booking maintenance |
| Around 3–6 months | Some PN studies continue to record improvement or satisfaction in this window | This is class-level evidence from other products, not a guaranteed AMI duration |
In a 42-person prospective periorbital PN cohort using a different product, participants received two sessions three weeks apart and reported the highest satisfaction at three months. A separate 30-person Asian PN study used three sessions at baseline, week 4 and week 8 and followed participants for six months. These studies help explain why gradual evaluation is sensible, but neither is an AMI trial and neither proves the best AMI Eyes schedule.
What can each product realistically change?
- AMI Eyes: look for a gradual change in fine crepiness, hydration and overall under-eye skin quality. Do not promise correction of a deep hollow, fat pad, edema or every dark-circle cause.
- AMI Plus X: look for gradual improvements in texture, hydration, fine lines and elasticity over the treated skin. It is not a volumizing filler and higher PN concentration does not ensure a dramatic lift.
- AMI Tone Up: compare tone evenness and brightness over at least several weeks while keeping sunscreen use consistent. It should not be sold as a guaranteed melasma cure; pigment disorders relapse and require diagnosis.
- AMI NAD+: treat claims such as “cellular revitalization” as formulation positioning until product-specific human outcomes are available. A result cannot be predicted from the biological importance of NAD+ alone.
- AMI Peptox: look for modest skin-quality or fine-line change, not paralysis of expression muscles or a Botox-like onset.
How should an AMI treatment course be planned?
A sensible course has a defined baseline, a limited initial series, and a scheduled review before maintenance. There is no independently established AMI-wide “optimal protocol,” and no online article can determine product amount, treatment method or suitability without examining the person and the current local instructions for use.
Independent PN literature commonly studies two to four sessions separated by roughly three to four weeks. A recent Asian PN consensus also describes two to four treatments at approximately four-week intervals for PN protocols. AMI commercial programmes often use shorter intervals. Those are different evidence layers, so they should not be blended into one supposedly proven schedule.
| Product | Published AMI/stockist programme | Evidence-aware way to use that information |
|---|---|---|
| AMI Eyes | Three sessions 10–14 days apart; maintenance around 4–6 months | Treat this as brand/stockist guidance, not an independent optimum. Compare it with the current IFU, local rules and the clinician’s assessment of periocular swelling risk |
| AMI Plus X | Four sessions about two weeks apart; maintenance often marketed around six months | The concentration does not validate the interval. Reassess photographs and skin quality after the initial series before planning maintenance |
| AMI Tone Up | Three initial sessions about 15 days apart, followed by two monthly sessions; later maintenance often marketed every 2–3 months | Pigment diagnosis, sun exposure and home photoprotection may matter more than adding sessions. Review tone under consistent lighting after 8–12 weeks |
| AMI NAD+ | Two to three sessions about one month apart; later maintenance often marketed every 2–3 months | This is a commercial programme with weak product-specific outcome evidence. Agree on a measurable goal and stop if the course does not deliver it |
| AMI Peptox | Retail protocols conflict, commonly suggesting two to five sessions separated by two to four weeks | The inconsistency is a reason to follow the current product documentation and a qualified clinician—not to copy the most aggressive online plan |
A practical four-step decision process
- Define one primary goal. “Improve under-eye crepiness” is measurable; “anti-ageing” is too vague.
- Record a baseline. Use standardized front and oblique photographs, consistent lighting, skincare and facial expression.
- Complete only the agreed initial series. Do not add products or sessions just because a box contains more vials.
- Review at the right time. For a regenerative course, 8–12 weeks is often more informative than the first few days. Maintenance should depend on a meaningful prior response, not a fixed sales calendar.
“How to use AMI Peptox” and “AMI Tone Up how to use” are common searches, but this guide deliberately does not provide injection depths, point maps, volumes, device settings, dilution or DIY instructions. Those decisions belong to the current product documentation and a licensed professional working within local regulations.
AMI aftercare: what to do after treatment
For the first 48 hours, protect the treated skin from unnecessary touching, makeup, heat, heavy exercise, swimming and other irritation; after that, let symptoms guide a gradual return to normal care. The exact instructions from the treating professional and current product documentation take priority.
| Time after treatment | Practical care |
|---|---|
| First 4 hours | Keep hands, phones and non-essential products away from the treated area. Do not press, rub or massage unless the treating professional specifically instructs it |
| First 24 hours | Avoid makeup and irritating actives over the treated skin. Use only the gentle cleanser or soothing care approved for the procedure. Do not pick at small raised points |
| First 48 hours | Avoid saunas, steam rooms, sunbeds, hot baths, strenuous exercise, swimming and heavy alcohol intake. These can aggravate heat, swelling, bruising or contamination risk |
| Days 3–7 | Resume products gradually if the skin is calm. Continue gentle cleansing, moisturization and broad-spectrum sunscreen. Avoid facials or devices that manipulate still-tender skin |
| Weeks 1–2 | Most mild reactions should be trending down. Compare standardized photographs only after swelling has settled; contact the clinic if symptoms persist or worsen |
Published AMI stockist guidance gives the four-hour, 24-hour and 48-hour milestones above for Tone Up and NAD+. General periocular PN guidance also emphasizes sun protection and temporarily limiting strenuous exercise, alcohol and heat. These are practical reference points, not proof that every AMI product, treatment route or patient needs an identical timetable.
Why sunscreen matters most with Tone Up
A brightening procedure cannot compensate for ongoing ultraviolet exposure. Daily broad-spectrum sunscreen and sensible sun avoidance make tone comparisons more meaningful and reduce a major trigger for recurrent pigmentation. If the target is melasma or post-inflammatory hyperpigmentation, diagnosis and a complete pigment plan are more important than choosing Tone Up from the ingredient list alone.
Side effects, warning signs and when to seek help
Temporary redness, tenderness, bruising, swelling and small raised points can occur; severe pain, skin colour change, visual symptoms or rapidly worsening swelling are not routine recovery. Under-eye tissue can hold fluid visibly, so AMI Eyes deserves especially careful candidate selection and follow-up.
Common short-term reactions can include:
- redness, warmth or tenderness at treated points;
- small papules or bumps that gradually flatten;
- bruising, itching or mild swelling;
- temporary unevenness while swelling settles;
- stinging or sensitivity, which is often discussed with multi-ingredient Tone Up treatments.
Contact the treating clinic promptly if redness, pain, warmth or swelling is increasing rather than improving; if a lump persists; or if there is drainage, fever, rash, marked itching or delayed swelling. Seek urgent medical assessment for severe or escalating pain, white/blanched or dusky/mottled skin, any visual change, sudden neurological symptoms, breathing difficulty or rapidly increasing asymmetric swelling.
These products are not made safe by being called “skin boosters.” Any procedure that breaches the skin can cause infection, bleeding, inflammatory reactions, scarring or injury. Periocular treatment also carries anatomy-specific risk. Product choice, sterile handling, treatment technique and complication readiness belong to an appropriately licensed professional.
Who may—or may not—be a suitable candidate?
Suitability depends on the cause of the concern, medical history, allergies, previous procedures and local product status—not only age or skin type. A clinician should review active skin disease, medications and earlier filler or booster treatments before planning a course.
Extra caution or postponement may be appropriate with active infection, open or inflamed skin, an uncontrolled dermatologic condition, pregnancy or breastfeeding, a history of severe allergic reactions, bleeding disorders or medicines that affect bleeding, immune-related disease, or a previous unexplained reaction to an injectable product. Do not stop a prescribed medicine because of an online article; discuss it with the prescriber and treating clinician.
Fish-derived ingredients need explicit screening
AMI Eyes is described as purified salmon-milt DNA, and current Plus X materials also describe salmon-derived PN. Tone Up product material combines a plant-derived exosome component with a salmon ingredient. AMI NAD+ contains PDRN, but the source and complete quantitative formula should be confirmed on the current package. Anyone with a fish allergy or uncertainty about animal-derived materials should not rely on the family name or the word “vegan”; the exact label must be checked.
Know when another treatment category fits better
- A deep tear-trough hollow or structural volume loss may need a different assessment than an eye-skin booster.
- Dynamic expression lines may respond to a licensed botulinum toxin treatment, while Peptox is a peptide skin booster and not a substitute.
- Diagnosed melasma or inflammatory pigmentation needs a complete dermatologic plan; Tone Up is not a stand-alone cure.
- Significant laxity or volume loss is unlikely to be corrected by a skin-quality product alone.
Regulatory status varies by country and by intended use. Availability from a distributor does not itself establish that a product is authorized for every procedure or jurisdiction. The buyer and treating professional should verify the exact current label, local rules and professional-use requirements before purchase or treatment.
AMI product sizes and specifications
The box size tells you how MJS sells the product; it does not tell you how much one person needs or how effective the formula is. Current product documents describe the single-container presentation, while MJS listings may bundle several vials as one sales pack.
| Product | Headline active | Single-container presentation | Current MJS sales pack | MJS product page |
|---|---|---|---|---|
| AMI Eyes | PN 1% | 1 × 2 mL pre-filled syringe | 1 × 2 mL | View AMI Eyes |
| AMI Plus X | PN 2% | 1 × 2 mL pre-filled syringe | 1 × 2 mL | View AMI Plus X |
| AMI Tone Up | PN + plant-derived extracellular-vesicle ingredient; brightening complex | 1 × 5 mL vial | 6 × 5 mL | View AMI Tone Up |
| AMI NAD+ | NAD+ + NMN + PDRN | 1 × 5 mL vial | 3 × 5 mL | View AMI NAD+ |
| AMI Peptox | Acetyl Hexapeptide-8, 5,000 ppm | 1 × 5 mL vial | 5 × 5 mL | View AMI Peptox |
The product information above was reviewed in September 2026. Packaging and local documentation can change, so the physical box, lot-specific documentation and current supplier page should be checked before a purchasing decision.
How can you check AMI product authenticity before buying?
Check the complete product identity, intact packaging, lot and expiry information, and any current anti-counterfeit feature before comparing price. Published AMI stockist materials describe a HiddenTag holographic verification system on certain outer sales packs, but sticker placement may differ between single-unit and multi-unit boxes.
Use this buyer checklist:
- Match the full name—Eyes, Plus X, Tone Up, NAD+ or Peptox—not only the AMI logo.
- Confirm the concentration or headline active and the container count against the current listing.
- Inspect the seal, lot number, expiry date and package condition before use.
- If a HiddenTag is present, scan it and confirm that the result identifies the expected AMI product; do not rely on the appearance of a sticker alone.
- Retain the box and treatment record so the exact product can be identified if a reaction occurs.
- Ask for the current instructions for use and verify professional and regulatory requirements in the treatment country.
Frequently asked questions
Which AMI product is best for under eyes?
AMI Eyes is the clearest AMI match when the goal is delicate under-eye skin quality, fine crepiness or skin-related shadowing. It contains 1% PN in a 2 mL syringe. It may not be the right answer for pigment-dominant circles, prominent edema, fat pads or a deep structural hollow, so the cause should be assessed before treatment.
Is AMI Plus X stronger than AMI Eyes?
Plus X has double the stated PN concentration: 2% versus 1%. That makes it the higher-concentration AMI PN presentation, not a clinically proven “twice as effective” product. The two are positioned for different tissue areas, and no controlled head-to-head AMI outcome trial was located.
What are the key AMI Tone Up ingredients?
Current product material identifies PN, glutathione and a plant-derived “vegan exosome” component, and published AMI material also lists niacinamide and tranexamic acid in the brightening complex. Check the complete current label before purchase because short product summaries do not always reproduce the full formula. The whole product should not be called vegan because the formula is also described with a salmon ingredient.
Does AMI Tone Up treat melasma?
It is positioned for tone and brightness, and some of its ingredients have a rational role in pigmentation care. That does not make the finished product a proven melasma cure. Melasma is recurrent and diagnosis, sunscreen, trigger control and a complete medical plan often matter more than one booster.
Does AMI NAD+ reverse skin ageing?
No such conclusion is supported by current product-specific evidence. NAD+ and NMN have important roles in cellular metabolism, and PDRN, niacinamide, adenosine and panthenol add a plausible skin-care rationale. However, no controlled peer-reviewed facial-rejuvenation trial of the finished AMI NAD+ formula was located, and the available product material does not state the quantitative active concentrations.
Is AMI Peptox the same as Botox?
No. AMI Peptox is a peptide skin booster led by Acetyl Hexapeptide-8 at 5,000 ppm. It is not botulinum toxin, is not measured in toxin units and does not have equivalent evidence for relaxing expression muscles.
How many AMI skin-booster sessions are needed?
There is no one proven AMI-wide number. Independent PN studies commonly use two to four sessions around three to four weeks apart, while AMI commercial programmes often use shorter spacing and product-specific series. A useful plan sets a measurable goal, follows the current product documentation and local regulations, and reviews the result after the initial course before adding maintenance.
How long do AMI skin-booster results last?
No reliable product-specific duration can be promised across this five-product range. PN studies using other products sometimes follow results for three to six months, while AMI stockist pages market maintenance at intervals ranging from two to six months. Treat those as planning references, not guarantees. The better question is whether standardized photographs show a meaningful response at 8–12 weeks and when that individual response begins to decline.
How long do AMI Eyes bumps or swelling last?
Small raised points, redness and swelling may settle within a few days, but the under-eye area can remain visibly puffy longer than other areas. Symptoms should trend downward. Increasing pain, colour change, visual symptoms, spreading redness, marked asymmetry or rapidly worsening swelling needs prompt professional assessment.
Can AMI products be used at home?
The AMI products in this guide are presented for professional use. Online DIY discussions often include unsafe depths, volumes and device settings that ignore anatomy, sterility, contraindications and complication management. This article does not reproduce them. Use should follow the current product documentation, local rules and a qualified professional’s assessment.
Compare the current AMI range at MJS
Start with the concern, then verify the exact formula and pack. Qualified buyers can compare AMI Eyes, AMI Plus X, AMI Tone Up, AMI NAD+ and AMI Peptox individually, or browse the wider MJS skin-booster collection.
Before ordering, confirm the current label, concentration, box count, lot and expiry details, storage conditions and regulatory status for the destination country. Product supply does not replace clinical diagnosis, professional training or treatment planning.
